AGTC strikes record deal with Biogen

AGTC and Biogen announce an agreement that could be worth $1 billion. Applied Genetic Technologies Corporation will receive $124 million up front for licensing for two of AGTC’s treatments as well as a stock purchase, granting Biogen 8% ownership. Not included in this payment is Biogen’s option to license 3 other genetic therapies that could total another $592.5 million.

This deal for Alachua-based AGTC marks it as the first UF spin-off to produce a billion dollar deal. The money will allow AGTC to more rapidly produce new therapies and continue hiring.

You can click here for more Front Street news.

Comment /Source

Virginia MacKoul

Virginia is a graduate from the University of Florida's College of Design Construction and Planning with a degree in Sustainability and the Built Environment, and a minor in Urban Regional Planning. Virginia joined the Front Street team in 2011, as an intern. Upon graduation, Virginia joined the Front Street team full-time as the Director of Client Services. Ms. MacKoul’s addition furthers Front Street’s continued growth and expansion within Gainesville and other North Central Florida markets. She was promoted to Director of Marketing in 2014 and now manages the firm’s team of interns and oversees all marketing and branding activity. Virginia was born in Boston and moved to Lee County, Florida in 1997. Virginia graduated her high school's International Baccalaureate program and started at the University of Florida with a focus on Architecture. Virginia shares Front Street's passion of giving back to the community and those in need. Virginia's hobbies include photography, cooking, football, movies, music, and spending time with her dog, Brinkley.

 Subscribe in a reader

Subscribe to Front Street's News Page by Email